SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-138563
Filing Date
2020-12-22
Accepted
2020-12-22 16:05:48
Documents
9
Period of Report
2020-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2039082d1_8k.htm 8-K 28193
2 EXHIBIT 3.1 tm2039082d1_ex3-1.htm EX-3.1 91394
3 EXHIBIT 4.1 tm2039082d1_ex4-1.htm EX-4.1 132527
4 EXHIBIT 5.1 tm2039082d1_ex5-1.htm EX-5.1 15061
5 EXHIBIT 10.1 tm2039082d1_ex10-1.htm EX-10.1 280394
6 EXHIBIT 99.1 tm2039082d1_ex99-1.htm EX-99.1 13970
7 GRAPHIC image_002.jpg GRAPHIC 2277
8 GRAPHIC tm2039082d1_ex99-1img001.jpg GRAPHIC 10594
9 GRAPHIC tm2039082d1_ex99-1img002.jpg GRAPHIC 4266
  Complete submission text file 0001104659-20-138563.txt   587012
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 201408023
SIC: 2834 Pharmaceutical Preparations